HD-OPM Archive
Topics › Statins

JAMA Intern Med: statin use linked to lower liver cancer and decompensation

Louis Nervegna · Mar 18, 2025 · ♥ 12 reactions · 2 comments · original Facebook post
StatinsWeight, visceral & liver fatCancer
↻ This is a repost. The main version (highest ranked) is Statin use linked to lower liver cancer and decompensation in chronic liver disease · May 19, 2025.
AI summary & key facts

Louis shares a JAMA Internal Medicine post reporting that statin use was associated with lower risk of hepatocellular carcinoma and hepatic decompensation, and with improved fibrosis progression, in patients with chronic liver disease. He presents it as further evidence that statins protect the liver.

More evidence that statins protect the liver in the long term.

#statinsliverHD #statinsHD #liverHD #statinscancerHD

Research cited

Statin use is associated with lower risks of hepatocellular carcinoma (HCC) and hepatic decompensation, and improved fibrosis progression in patients with chronic liver disease. Statin Use and Risk of Hepatocellular Carcinoma and Liver Fibrosis in Chronic Liver… (JAMA Intern Med, 2025)

No photo description available.
← newer: Two years of structured exercise reversed up to 20 years of older: PCSK9 gene-editing therapy may not be safe yet; patient deat →